EP3191513
Notkun á reslísúmab til að meðhöndla miðlungs til alvarlegan rauðkyrningaastma
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.8.2015EP published:
24.6.2020EP application number:
15760590.8
EP translation filed:
19.8.2020Grant published:
15.9.2020EPO information:
European Patent Register
Max expiry date:
27.8.2035Expiry date:
27.8.2026Next due date:
31.8.2026
Title:
USE OF RESLIZUMAB TO TREAT MODERATE TO SEVERE EOSINOPHILIC ASTHMA
Timeline
Today
28.8.2015EP application
24.6.2020EP Publication
19.8.2020Translation submitted
15.9.2020Registration published
27.8.2026Expires
Owner
Name:
Cephalon LLCAddress:
145 Brandywine Parkway, West Chester, Pennsylvania 19380, US
Inventor
Name:
BRUSSELLE, GuyAddress:
9840 De Pinte, BE
Name:
O'BRIEN, ChristopherAddress:
Lafayette Hill, PA 19444, US
Name:
ZANGRILLI, JamesAddress:
Philadelphia, PA 19103, US
Name:
SHAH, TusharAddress:
Flemington, NJ 08022, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462047248 PDate:
8.9.2014Country:
US
Number:
201462091150 PDate:
12.12.2014Country:
US
Number:
201562168007 PDate:
29.5.2015Country:
US
Number:
201562191690 PDate:
13.7.2015Country:
US
Classification
Categories:
C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 11.8.2020
Expires: 27.8.2021
Payer: Tego ehf.
Number: 7
Paid: 10.8.2021
Expires: 27.8.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 8
Paid: 10.8.2022
Expires: 27.8.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 20.7.2023
Expires: 27.8.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 23.7.2024
Expires: 27.8.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.8.2025
Expires: 27.8.2026
Payer: Árnason Faktor ehf.